Opaleye Management Inc. - 10 Jun 2025 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Reporting relationship: 10%+ Owner
Issuer ticker: ETON
Reported as of: 10 Jun 2025
Net transaction value: +$125,484
SEC form: 4
Accepted by SEC: 12 Jun 2025, 16:32:51 UTC
Prior SEC filing: 11 Jun 2025
Next SEC filing: 16 Jun 2025
Source filing: View source filing
Reporting owner signature: Opaleye Management Inc., By: /s/ James Silverman, President

Key filing fact

Opaleye Management Inc. filed Form 4 for Eton Pharmaceuticals, Inc. (ETON) on 12 Jun 2025.

Key facts

This page summarizes Opaleye Management Inc.'s Form 4 filing for Eton Pharmaceuticals, Inc. (ETON).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 12 Jun 2025, 16:32.

Change

Previous filing in this sequence was filed on 11 Jun 2025.
Current net transaction value: +$125,484.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001595855 Primary reporting owner

Opaleye Management Inc.

Relationship: 10%+ Owner
Address: ONE BOSTON PLACE, 26TH FLOOR, BOSTON
Signature: Opaleye Management Inc., By: /s/ James Silverman, President
Signature date: 12 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ETON transaction

Common Stock, par value $0.001 per share

Purchase

Transaction value: $79,120
Shares: +5,000
Change %: +0.18%
Price: $15.82
Shares after: 2,770,000
Date: 10 Jun 2025
Ownership: By Opaleye, L.P.
Footnotes: F1, F3, F4

ETON transaction

Common Stock, par value $0.001 per share

Purchase

Transaction value: $46,364
Shares: +2,930
Change %: +3.6%
Price: $15.82
Shares after: 85,000
Date: 10 Jun 2025
Ownership: Managed Account
Footnotes: F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

Footnote F2

Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

Footnote F3

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.74 to $15.9742 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.

Footnote F4

Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.